O'Brien M - Search Results

1

Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy.

Popat S, Januszewski A, O'Brien M, Ahmad T, Lewanski C, Dernedde U, Jankowska P, Mulatero C, Shah R, Hicks J, Geldart T, Cominos M, Gray G, Spicer J, Bell K, Roitt S, Morris C, Ngai Y, Hughes L, Hackshaw A, Wilson W. Popat S, et al. Br J Cancer. 2024 Dec 5. doi: 10.1038/s41416-024-02901-6. Online ahead of print. Br J Cancer. 2024. PMID: 39639088

2

Chemotherapy strategies in the treatment of small cell lung cancer.

Popat S, O'Brien M. Popat S, et al. Anticancer Drugs. 2005 Apr;16(4):361-72. doi: 10.1097/00001813-200504000-00002. Anticancer Drugs. 2005. PMID: 15746572 Review.

3

Treatment options for small cell lung cancer - do we have more choice?

Puglisi M, Dolly S, Faria A, Myerson JS, Popat S, O'Brien ME. Puglisi M, et al. Br J Cancer. 2010 Feb 16;102(4):629-38. doi: 10.1038/sj.bjc.6605527. Epub 2010 Jan 26. Br J Cancer. 2010. PMID: 20104223 Free PMC article. Review.

4

Supersensitive mutation: two case reports of non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Myerson JS, Iqbal SA, O'Brien ME, Popat S. Myerson JS, et al. Clin Lung Cancer. 2010 Sep 1;11(5):E5-8. doi: 10.3816/CLC.2010.n.047. Clin Lung Cancer. 2010. PMID: 20837451

5

Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors.

Leary AF, Castro DG, Nicholson AG, Ashley S, Wotherspoon A, O'Brien ME, Popat S. Leary AF, et al. Eur J Cancer. 2012 Jan;48(1):61-7. doi: 10.1016/j.ejca.2011.09.022. Epub 2011 Oct 27. Eur J Cancer. 2012. PMID: 22036089

6

Time and chemotherapy treatment trends in the treatment of elderly patients (age >/=70 years) with small cell lung cancer.

Yau T, Ashley S, Popat S, Norton A, Matakidou A, Coward J, O'Brien ME. Yau T, et al. Br J Cancer. 2006 Jan 16;94(1):18-21. doi: 10.1038/sj.bjc.6602888. Br J Cancer. 2006. PMID: 16317431 Free PMC article.

7

Under usage of zoledronic acid in non-small cell lung cancer patients with metastatic bone disease--a short communication.

Calderone R, Nimako K, Leary A, Popat S, O'Brien ME. Calderone R, et al. Eur J Cancer. 2011 Jul;47(11):1603-5. doi: 10.1016/j.ejca.2011.05.008. Epub 2011 Jun 16. Eur J Cancer. 2011. PMID: 21684152

8

Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survival.

Sirohi B, Ashley S, Norton A, Popat S, Hughes S, Papadopoulos P, Priest K, O'Brien M. Sirohi B, et al. J Thorac Oncol. 2007 Aug;2(8):735-40. doi: 10.1097/JTO.0b013e31811f3a7d. J Thorac Oncol. 2007. PMID: 17762340 Free article.

9

A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients.

Kumar R, Lu SK, Minchom A, Sharp A, Davidson M, Gunapala R, Yap TA, Bhosle J, Popat S, O'Brien ME. Kumar R, et al. Cancer Chemother Pharmacol. 2016 Feb;77(2):375-83. doi: 10.1007/s00280-015-2950-1. Epub 2015 Dec 26. Cancer Chemother Pharmacol. 2016. PMID: 26706729

10

Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?

Capelan M, Roda D, Geuna E, Rihawi K, Bodla S, Kaye SB, Bhosle J, Banerji U, O'Brien M, de Bono JS, Popat S, Yap TA. Capelan M, et al. Lung Cancer. 2017 Sep;111:6-11. doi: 10.1016/j.lungcan.2017.06.005. Epub 2017 Jun 15. Lung Cancer. 2017. PMID: 28838399 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,440 results

Search Page

Filters